Legal Representation
Attorney
David Farah
USPTO Deadlines
Application History
24 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 10, 2006 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Jan 10, 2006 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Apr 13, 2005 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Apr 13, 2005 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Apr 13, 2005 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 12, 2004 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Oct 25, 2004 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Oct 25, 2004 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 27, 2004 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| May 5, 2004 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| May 11, 2004 | CFIT | O | CASE FILE IN TICRS | Loading... |
| May 11, 2004 | CFIT | O | CASE FILE IN TICRS | Loading... |
| May 5, 2004 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 10, 2003 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Oct 30, 2003 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Oct 30, 2003 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 6, 2003 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Feb 11, 2003 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 22, 2003 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Dec 1, 2002 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 22, 2002 | CNEA | O | EXAMINERS AMENDMENT MAILED | Loading... |
| Oct 22, 2002 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
| Oct 10, 2002 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 26, 2002 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 042
research and development of new products for others in the nature of designing biological molecules, including polynucleotides, polypeptides and vectors; chemical analysis services in the nature of evaluating biological molecules, including polynucleotides, polypeptides and vectors; research and development of new products for others, namely, services producing biological molecules, including polynucleotides, polypeptides and vectors; pharmaceutical drug development services for others; chemical analysis and scientific research services in the field of drug development, namely evaluating the activity of drugs and candidate substances for drugs for others
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
042